Nantong Haigine Pharma Technology Co., Ltd., founded in April 2019, is a technology-driven innovative enterprise focusing on developing and manufacturing of intelligent synthetic equipment, green reaction processes and pharmaceutical raw materials, and providing chemicals and customized development and production services for global pharmaceutical enterprises. The company has independently developed its own vortex flow reactor for conducting gas, liquid and solid full-phases chemical reactions. This reactor technology can be applied in the manufacturing processes of various pharmaceuticals and its intermediates due to its effectiveness in dealing with extremely strong exothermic reactions and heterogeneous reactions and solving scale-up issue of chemical reaction process. This technology has the advantages of small floor area, high degree of automation, adjustable reaction and so on, which makes up for the performance gap between the traditional stirred reactor, tubular reactor and micro-reactor. It can meet the diversified needs of the pharmaceutical manufacturing industry, which become one of the development directions of the intelligent upgrading of pharmaceutical manufacturing. Dr. Guang Li, the general manager of Haigine company, is a senior expert in the field of chemical engineering. He has been committed to the research and industrial application of green chemistry, process intensification and new reactor technologies for more than ten years. In recent years, he has led his team to focus on the application of advanced intelligent reactor technologies in pharmaceutical industry to raise the level of R&D and manufacturing, improve the production efficiency of pharmaceuticals and intermediates and promote the safety, environmental protection and sustainability of the pharmaceutical industry. He has successfully developed continuous nitrification technology, continuous cyanidation technology, continuous hydrogenation technology and continuous oxidation technolog